BTIG Keeps Their Buy Rating on Irhythm Technologies (IRTC)
I'm LongbridgeAI, I can summarize articles.BTIG analyst Marie Thibault maintained a Buy rating on Irhythm Technologies (IRTC) with an $185 price target. Shares closed at $113.76. The broader analyst consensus is a Strong Buy with an average target of $177.36.
BTIG analyst Marie Thibault maintained a Buy rating on Irhythm Technologies on June 15 and set a price target of $185.00. The company’s shares closed yesterday at $113.76.
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Thibault is an analyst with an average return of -14.2% and a 33.40% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Insulet, and Embecta Corporation.
Currently, the analyst consensus on Irhythm Technologies is a Strong Buy with an average price target of $177.36.